This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Relay Therapeutics, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Elisabeth Isaak: Innovator in FGFR Inhibitors
Introduction
Elisabeth Isaak is a prominent inventor based in Hertfordshire, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. Her work is crucial in advancing treatments for various medical conditions.
Latest Patents
Elisabeth holds a patent for "FGFR inhibitors and methods of making and using the same." This patent is directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide, along with its salts, cocrystals, and variants. This innovation represents a significant advancement in the pharmaceutical industry.
Career Highlights
Elisabeth is currently associated with Relay Therapeutics, Inc., where she continues to push the boundaries of drug development. Her expertise and innovative approach have positioned her as a key player in her field.
Collaborations
Elisabeth has collaborated with notable colleagues, including André Lescarbeau and Jethro Beamish-Cook. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Elisabeth Isaak's contributions to the field of FGFR inhibitors exemplify her dedication to innovation in pharmaceuticals. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes.